NCT02684721

Brief Summary

In a randomised design the study aims to investigate whether an intervention of 8 weeks home-based exercise in addition to usual care can positively influence the physical capacity, quality of life, sick leave and use of psychoactive drugs in patients medically treated for pulmonary embolism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2016

Completed
29 days until next milestone

First Posted

Study publicly available on registry

February 18, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

August 19, 2019

Status Verified

November 1, 2016

Enrollment Period

2.4 years

First QC Date

January 20, 2016

Last Update Submit

August 14, 2019

Conditions

Keywords

rehabilitationphysical capacityquality of life

Outcome Measures

Primary Outcomes (1)

  • Change in Incremental Shuttle Walk test from baseline to 6 months after baseline

    Validated outcome measure for assessing a person's maximum walking capacity

    Baseline, 2 months and 6 months after baseline

Secondary Outcomes (4)

  • Change in Pulmonary Embolism Quality of Life from baseline to 6 months

    Baseline, 2 months and 6 months after baseline

  • Change in EuroQol 5 Dimensions (EQ-5D) from baseline to 6 months

    Baseline, 2 months and 6 months after baseline

  • Sick leave in the past 4 weeks measured at 2 and 6 month follow-up

    Baseline, 2 months and 6 months after baseline

  • Average weekly use of psychoactive drugs in the past 4 weeks measured at 2 and 6 month follow-up

    Baseline, 2 months and 6 months after baseline

Study Arms (2)

Control group

NO INTERVENTION

Patients in the control group receive usual care as a minimum. This includes 3-5 days of hospitalisation where the anticoagulant treatment is initiated. The patient and the relatives receive general information about the disease and the course of treatment, the medication and future prevention of embolism. In the year following discharge the patient is booked for a check-up of their anticoagulant treatment with a physician or a nurse as required.

Exercise group

EXPERIMENTAL

8-week home-base exercise programme: Patients in the intervention group receive the same usual care as patients in the control group. In addition the patients participate in an 8 week home-based exercise programme, including follow-up telephone calls with the physiotherapist after 1 week, 2 weeks and 4 weeks. Briefly put, the patients are required to exercise for a minimum of 3 times per week for 30-60 minutes, and with 3-4 intervals of approximately 1 minute at a high intensity level. Total exercise time and intervals increase during the 8 week programme. The patients can choose whatever type of exercise they prefer, and they are generally encouraged to choose something they already do, or something that they have previously had positive experiences doing.

Other: 8-week home-based exercise programme

Interventions

8-week home-based exercise programme is assigned to patients in exercise group following discharge. This includes 3 follow-up telephone calls by physiotherapist.

Exercise group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Objectively verified acute pulmonary embolism
  • Treatment with anticoagulant drugs
  • years of age
  • Competency in the Danish language

You may not qualify if:

  • Pulmonary embolism as a secondary finding in relation to scan performed due to another disease.
  • Severe co-morbidity (malignant, inflammatory or psychiatric)
  • Unable to perform the Incremental Shuttle Walk test for other reasons (e.g. amputation or intermittent claudication).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Aalborg University Hospital

Aalborg, 9000, Denmark

Location

Regional hospital Herning

Herning, 7400, Denmark

Location

Diagnostic Centre, Regional Hospital Silkeborg

Silkeborg, 8600, Denmark

Location

Related Publications (3)

  • Rolving N, Brocki BC, Mikkelsen HR, Ravn P, Bloch-Nielsen JR, Frost L. Does an 8-week home-based exercise program affect physical capacity, quality of life, sick leave, and use of psychotropic drugs in patients with pulmonary embolism? Study protocol for a multicenter randomized clinical trial. Trials. 2017 May 30;18(1):245. doi: 10.1186/s13063-017-1939-y.

    PMID: 28558825BACKGROUND
  • Rolving N, Brocki BC, Andreasen J. Coping with everyday life and physical activity in the aftermath of an acute pulmonary embolism: A qualitative study exploring patients' perceptions and coping strategies. Thromb Res. 2019 Oct;182:185-191. doi: 10.1016/j.thromres.2019.06.007. Epub 2019 Jun 19.

    PMID: 31262439BACKGROUND
  • Rolving N, Brocki BC, Bloch-Nielsen JR, Larsen TB, Jensen FL, Mikkelsen HR, Ravn P, Frost L. Effect of a Physiotherapist-Guided Home-Based Exercise Intervention on Physical Capacity and Patient-Reported Outcomes Among Patients With Acute Pulmonary Embolism: A Randomized Clinical Trial. JAMA Netw Open. 2020 Feb 5;3(2):e200064. doi: 10.1001/jamanetworkopen.2020.0064.

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Nanna Rolving, PhD

    Diagnostic Centre, Regional Hospital Silkeborg, Silkeborg, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2016

First Posted

February 18, 2016

Study Start

April 1, 2016

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

August 19, 2019

Record last verified: 2016-11

Locations